TSVT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TSVT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). 2seventy bio's Average Total Inventories for the three months ended in Sep. 2024 was $0.00 Mil. 2seventy bio's Cost of Goods Sold for the three months ended in Sep. 2024 was $5.77 Mil. Hence, 2seventy bio's Days Inventory for the three months ended in Sep. 2024 was 0.00.
The historical rank and industry rank for 2seventy bio's Days Inventory or its related term are showing as below:
2seventy bio's Days Inventory stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. 2seventy bio's Inventory-to-Revenue for the three months ended in Sep. 2024 was 0.00.
The historical data trend for 2seventy bio's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2seventy bio Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Days Inventory | Get a 7-Day Free Trial | - | - | - | - | - |
2seventy bio Quarterly Data | ||||||||||||||||||||
Dec18 | Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Days Inventory | Get a 7-Day Free Trial | - | - | - | - | - |
For the Biotechnology subindustry, 2seventy bio's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, 2seventy bio's Days Inventory distribution charts can be found below:
* The bar in red indicates where 2seventy bio's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
2seventy bio's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 16.918 | * | 365 |
= | 0 | / | 16.918 | * | 365 | ||||
= | 0.00 |
2seventy bio's Days Inventory for the quarter that ended in Sep. 2024 is calculated as:
Days Inventory (Q: Sep. 2024 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Jun. 2024 ) | + | Total Inventories (Q: Sep. 2024 )) | / | count ) | / | Cost of Goods Sold (Q: Sep. 2024 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 5.768 | * | 365 / 4 |
= | 0 | / | 5.768 | * | 365 / 4 | ||||
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2seventy bio (NAS:TSVT) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
2seventy bio's Inventory Turnover for the three months ended in Sep. 2024 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 5.768 | / | 0 | |
= |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
2seventy bio's Inventory to Revenue for the three months ended in Sep. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 0 | / | 13.534 | |
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of 2seventy bio's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Marcela V. Maus | director | 16 RICHMOND CIRCLE, LEXINGTON MA 02421 |
Nick Leschly | director, officer: President and CEO | C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Baird William D Iii | officer: Chief Financial Officer | C/O BLUEBIRD BIO, INC., 60 BINNEY STREET, CAMBRIDGE MA 02142 |
Philip D Gregory | officer: Chief Scientific Officer | POINT RICHMOND TECH CENTER II, 501 CANAL BOULEVARD SUITE A100, RICHMOND CA 94804 |
Kynam Capital Management, Lp | 10 percent owner | 221 ELM ROAD, PRINCETON NJ 08540 |
Kynam Capital Management Gp, Llc | 10 percent owner | 221 ELM ROAD, PRINCETON NJ 08540 |
Kynam Global Healthcare Master Fund, Lp | 10 percent owner | 221 ELM ROAD, PRINCETON NJ 08540 |
Kynam Fund Gp, Llc | 10 percent owner | 221 ELM ROAD, PRINCETON NJ 08540 |
Yue Tang | 10 percent owner | 221 ELM ROAD, PRINCETON NJ 08540 |
Nicola Heffron | officer: Chief Operating Officer | 2SEVENTY BIO, INC., 60 BINNEY STREET, CAMBRIDGE MA 02142 |
Daniel Lynch | director | |
Denice Torres | director | 3 RABBIT RUN DRIVE, NEW HOPE PA 18938 |
Sarah Js Glickman | director | 60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142 |
Ramy Ibrahim | director | C/O SURFACE ONCOLOGY, 50 HAMPSHIRE STREET, 8TH FLOOR, CAMBRIDGE MA 02139 |
William R. Sellers | director | C/O BLUEBIRD BIO, INC., 60 BINNEY STREET, CAMBRIDGE MA 02142 |
From GuruFocus
By Business Wire • 06-26-2024
By GuruFocus Research • 08-09-2024
By Business Wire • 10-08-2024
By Business Wire • 08-07-2024
By Marketwired • 09-27-2024
By GuruFocus Research • 05-09-2024
By Business Wire • 11-04-2024
By PRNewswire • 10-07-2024
By Business Wire • 05-23-2024
By GuruFocus Research • 05-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.